Videos

Neoadjuvant Endocrine Therapy vs De-Escalated Chemotherapy for HR-Positive, HER2-Positive Early Breast Cancer

09/15/2024

Oleg Gluz, MD, discusses results from the phase 2 WSG-TP-II trial which investigated survival outcomes with neoadjuvant endocrine therapy plus trastuzumab and pertuzumab vs de-escalated chemotherapy plus trastuzumab and pertuzumab in...

Oleg Gluz, MD, discusses results...

09/15/2024

Oncology

Videos

Nivolumab Plus Ipilimumab Improves Overall Survival Over Standard of Care Therapy in Advanced Non-Clear Cell Renal Cancer

09/14/2024

Lothar Bergmann, MD, discusses results from the phase 2 SUNNIFORECAST trial which assessed the efficacy of combination immunotherapy in patients with advanced non-clear cell renal cancers.

Lothar Bergmann, MD, discusses...

09/14/2024

Oncology

Videos

Amivantamab Plus Chemotherapy Demonstrates Antitumor Activity in Metastatic Colorectal Cancer

09/14/2024

Filippo Piertrantonio, MD, discusses results from the OrigAMI-1 study, which determined that amivantamab combined with FOLFOX or FOLFIRI demonstrates antitumor activity in patients with RAS/RAF-wild type metastatic colorectal cancer.

Filippo Piertrantonio, MD,...

09/14/2024

Oncology

Videos

Adding Relatlimab to First-Line Nivolumab and Chemotherapy Demonstrates Clinical Benefit in Advanced Non-Small Cell Lung Cancer

09/14/2024

Nicolas Girard , MD;

Nicolas Girard, MD, PhD, discusses results from the phase 2 RELATIVITY-104 study which demonstrated clinical benefit in adding relatlimab to first-line nivolumab plus platinum-doublet chemotherapy among patients with advanced or recurrent...

Nicolas Girard, MD, PhD,...

09/14/2024

Oncology

Videos

Pediatric Video Tutorial: The Future of BVMs

09/14/2024

Scott DeBoer , RN, MSN, CPEN, CEN, CCRN, CFRN;

Scott and Lisa DeBoer broadcast live from EMS World Expo 2024 in Las Vegas and interview Jonathan Merrell about a revolutionary BVM device designed to save lungs from overventilation.

Scott and Lisa DeBoer broadcast...

09/14/2024

EMSWorld

Videos

Pirtobrutinib Therapy in the R/R Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Treatment Landscape

09/13/2024

Inhye Ahn, MD, shares insight into non-covalent BTK inhibitor pirtobrutinib treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least 2 prior lines of therapy.

Inhye Ahn, MD, shares insight...

09/13/2024

Oncology

Videos

Updates in Novel and Cellular Therapies for Patients With R/R Multiple Myeloma

09/12/2024

Jonathan Kaufman, MD, discusses recent updates for treating patients with relapsed/refractory multiple myeloma with new and immune cellular therapies.

Jonathan Kaufman, MD, discusses...

09/12/2024

Oncology

Videos

Incidence of Endometrial Cancer Among BRCA1/2 Mutation Carriers

09/12/2024

Steve Narod, MD, discusses the incidence of endometrial cancer among people who are BRCA mutation carriers.

Steve Narod, MD, discusses the...

09/12/2024

Oncology

Conference Coverage

Utilizing and Selecting Optimal JAK Inhibitor Therapies for Patients With Myelofibrosis

09/12/2024

John Mascarenhas , MD;

At the 2024 SOHO meeting, John Mascarenhas, MD, shares highlights from a discussion on the utilization and selection of optimal JAK inhibitor therapies for the treatment of patients with myelofibrosis.

At the 2024 SOHO meeting, John...

09/12/2024

Oncology

Videos

Innovations in Regenerative Medicine

09/12/2024

Neil S. Sadick , MD, FAAD;

In this interview, Dr Sadick explores cutting-edge advancements in regenerative medicine, including PRP, exosomes, and cell banking, and their potential to revolutionize dermatology. Key insights are provided on emerging technologies and...

In this interview, Dr Sadick...

09/12/2024

The Dermatologist